To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation Reversal

NOTE: This session is part of the Live Intensive Studies and Clinical Sessions packages. All attendees may attend these thought-provoking and highly educational sessions. However, if you are board-certified, you must purchase the package(s) for your specialty to receive the recertification assessment and claim the recertification credit.

Given the urgency and gravity of the decision to reverse anticoagulation, it is important for pharmacists to be aware of the key patient-specific factors that will influence patient safety. While some clinical scenarios necessitate anticoagulation reversal, these are accompanied by the potential for further complications. Using patient cases, this interactive session will provide a comprehensive overview of the various strategies for individual anticoagulant reversal, including agent selection, laboratory monitoring, and pharmacokinetic data while initially weighing the risk versus benefit of anticoagulation reversal and the approach to agent selection. New and emerging data that may influence clinical and operational pharmacy decisions (e.g., agents, formulary management) will also be presented.

This activity is approved for Board-Certified Critical Care Pharmacist (BCCCP) and Board-Certified Emergency Medicine Pharmacist (BCEMP) recertification credit.